JP2013537426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013537426A5 JP2013537426A5 JP2013524945A JP2013524945A JP2013537426A5 JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5 JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- cancer
- item
- orf3
- impaired
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37421510P | 2010-08-16 | 2010-08-16 | |
| US61/374,215 | 2010-08-16 | ||
| PCT/US2011/048005 WO2012024350A2 (en) | 2010-08-16 | 2011-08-16 | Anti-cancer adenoviruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013537426A JP2013537426A (ja) | 2013-10-03 |
| JP2013537426A5 true JP2013537426A5 (enExample) | 2014-09-18 |
| JP5905460B2 JP5905460B2 (ja) | 2016-04-20 |
Family
ID=45605646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524945A Active JP5905460B2 (ja) | 2010-08-16 | 2011-08-16 | 抗がんアデノウイルス |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9187733B2 (enExample) |
| EP (1) | EP2606137B1 (enExample) |
| JP (1) | JP5905460B2 (enExample) |
| KR (1) | KR101667094B1 (enExample) |
| CN (1) | CN103180448B (enExample) |
| AU (1) | AU2011292119B2 (enExample) |
| BR (1) | BR112013003579A2 (enExample) |
| CA (1) | CA2807778C (enExample) |
| SG (1) | SG187785A1 (enExample) |
| WO (1) | WO2012024350A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011292119B2 (en) * | 2010-08-16 | 2015-06-11 | Salk Institute For Biological Studies | Anti-cancer adenoviruses |
| JP6170999B2 (ja) * | 2012-03-13 | 2017-07-26 | ソーク インスティテュート フォー バイオロジカル スタディーズ | アデノウイルスおよび化学二量体を用いる選択細胞の標的化 |
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| PL3198009T3 (pl) | 2014-09-24 | 2022-01-24 | Salk Institute For Biological Studies | Onkolityczne wirusy nowotworowe i sposoby zastosowania |
| ES2837400T3 (es) | 2015-10-05 | 2021-06-30 | Salk Inst For Biological Studi | Adenovirus sintético con tropismo para los tejidos dañados para su uso en la promoción de la reparación de heridas y regeneración tisular |
| JP7054527B2 (ja) | 2016-02-23 | 2022-04-14 | ソーク インスティテュート フォー バイオロジカル スタディーズ | アデノウイルスの複製動態を測定するための高スループットアッセイ |
| JP7015551B2 (ja) | 2016-02-23 | 2022-02-15 | ソーク インスティテュート フォー バイオロジカル スタディーズ | ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現 |
| WO2018111767A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| TW201907937A (zh) | 2017-05-08 | 2019-03-01 | 美商葛利史東腫瘤科技公司 | 阿爾法病毒新抗原載體 |
| JP7430395B2 (ja) | 2018-04-09 | 2024-02-13 | ソーク インスティテュート フォー バイオロジカル スタディーズ | 複製特質が増強された腫瘍溶解性アデノウイルス組成物 |
| MX2021014525A (es) * | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA137094A (en) | 1911-08-31 | 1911-11-28 | Sheppe, Alice L. | Cloth measuring and price calculating machine |
| FR2726285B1 (fr) * | 1994-10-28 | 1996-11-29 | Centre Nat Rech Scient | Adenovirus depourvus de particules contaminantes viables, preparation et utilisation |
| ES2180258T3 (es) * | 1998-07-07 | 2003-02-01 | Transgene Sa | Utilizacion de pautas de lectura abierta adenovirales de e4 para mejorar la expresion de genes. |
| EP1083229A1 (en) * | 1999-09-10 | 2001-03-14 | Introgene B.V. | Modified adenoviral vectors for use in gene therapy |
| CN1293196C (zh) | 2000-05-26 | 2007-01-03 | 大日本住友制药株式会社 | 具有副作用降低的特性的新型重组腺病毒载体 |
| US20020106382A1 (en) * | 2000-07-14 | 2002-08-08 | Young Charles S.H. | Modified adenovirus and uses thereof |
| US20030220284A1 (en) | 2002-02-22 | 2003-11-27 | Patricia Yotnda | Delivery of adenoviral DNA in a liposomal formulation for treatment of disease |
| WO2003092579A2 (en) | 2002-04-29 | 2003-11-13 | Hadasit Medical Research Services And Development Company Ltd. | Compositions and methods for treating cancer with an oncolytic viral agent |
| EP1545627A4 (en) | 2002-10-01 | 2006-12-27 | Univ Duke | TARGETED TUMOR THERAPY THROUGH THE USE OF RECOMBINANT ADENOVIRUS VECTORS FOR SELECTIVE REPLICATION IN HYPOXIC TUMOR REGIONS |
| US20050201978A1 (en) | 2003-11-17 | 2005-09-15 | Lipton James S. | Tumor and infectious disease therapeutic compositions |
| KR20110081222A (ko) * | 2008-09-26 | 2011-07-13 | 어번 유니버시티 | 비복제성 벡터화된 백신의 점막 투여에 의한 조류의 면역화 |
| AU2011292119B2 (en) * | 2010-08-16 | 2015-06-11 | Salk Institute For Biological Studies | Anti-cancer adenoviruses |
-
2011
- 2011-08-16 AU AU2011292119A patent/AU2011292119B2/en active Active
- 2011-08-16 BR BR112013003579A patent/BR112013003579A2/pt not_active Application Discontinuation
- 2011-08-16 WO PCT/US2011/048005 patent/WO2012024350A2/en not_active Ceased
- 2011-08-16 SG SG2013009790A patent/SG187785A1/en unknown
- 2011-08-16 CA CA2807778A patent/CA2807778C/en active Active
- 2011-08-16 JP JP2013524945A patent/JP5905460B2/ja active Active
- 2011-08-16 EP EP11818698.0A patent/EP2606137B1/en active Active
- 2011-08-16 CN CN201180050032.7A patent/CN103180448B/zh active Active
- 2011-08-16 KR KR1020137006526A patent/KR101667094B1/ko active Active
-
2013
- 2013-02-15 US US13/768,933 patent/US9187733B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barkauskas et al. | Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis | |
| AR090470A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
| MX2024005757A (es) | Virus pichinde de tres segmentos como vectores de vacunas. | |
| BR112016020688A2 (pt) | Composições úteis no tratamento da deficiência da ornitina transcarbamilase (otc) | |
| SA520412637B1 (ar) | B7 الفيروس الغدي الحال للورم المشفِّر لبروتين | |
| JP2013530155A5 (enExample) | ||
| EA201301173A1 (ru) | Клональные штаммы аттенуированных вакцинирующих вирусов и способы их использования | |
| FR2981643B1 (fr) | Procede de preparation d'un materiau composite silicium/carbone, materiau ainsi prepare, et electrode notamment electrode negative, comprenant ce materiau. | |
| WO2015061294A3 (en) | Use of sting agonists to treat chronic hepatitis b virus infection | |
| BR112014015016A8 (pt) | Proteína homodimérica de duas cadeias de aminoácidos idênticas, cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica, célula hospedeira, método de preparação de uma proteína homodimérica, método para preparação de uma vacina, vacina e método de tratamento ou prevenção | |
| IN2015DN00376A (enExample) | ||
| JP2018512047A5 (enExample) | ||
| FI3581650T3 (fi) | IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi | |
| BR112015008930A2 (pt) | vacinas baseadas em partícula recombinante contra a infecção por citomegalovírus humano | |
| JP2011157399A5 (enExample) | ||
| NZ628385A (en) | Batches of recombinant adenovirus with altered terminal ends | |
| BR112014028315A2 (pt) | mposto, métodos para introdução de uma molécula dentro do citosol de uma célula, para obter a morte de uma célula, para expressar uma molécula antigênica ou uma parte da mesma na superfície de uma célula, e para tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, composição farmacêutica, célula ou uma população de células, e, kit | |
| PE20142435A1 (es) | Particulas inhalables que comprenden tiotropio | |
| MD4481B1 (ro) | Herpesvirus recombinant Koi (KHV) şi vaccin pentru profilaxia bolii cauzate de KHV | |
| EA201401353A1 (ru) | Биомаркеры для определения эффективной ответной реакции на лечение пациентов с гепатоцеллюлярной карциномой (гцк) | |
| JP2018512597A5 (enExample) | ||
| JP2013544892A5 (enExample) | ||
| EP2903632A4 (en) | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETES PATIENTS | |
| Hu et al. | Oncolytic viruses for the treatment of bladder cancer: advances, challenges, and prospects | |
| JP2015044878A5 (enExample) |